Coldstream Capital Management Inc Lyell Immunopharma, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,166 shares of LYEL stock, worth $501. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,166Holding current value
$501% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
116Shares Held
171MCall Options Held
7.7KPut Options Held
15.3K-
Mwg Management Ltd. Washington, DC20.2MShares$8.67 Million18.54% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$6.49 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$6.49 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$5.8 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$5.12 Million1.8% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $107M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...